Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast
|
|
- Silvia Walters
- 6 years ago
- Views:
Transcription
1 Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast ROBERT BARNES, M.D. AND SHAHLA MASOOD, M.D. The estrogen receptor (ER) expression of invasive breast cancer has been extensively studied both biochemically and with specific monoclonal antibodies against ER. Relatively few studies have attempted to characterize ER pattern in breast carcinoma in situ (CIS) and in other premalignant lesions. In the current study, the authors investigated the pattern of ER expression in 62 cases of breast CIS, 30 of which had a component of invasive cancer, and 36 cases of atypical hyperplasia. Paraffin sections of formalin-fixed breast tissue underwent enzyme pretreatment to expose nuclear antigenic sites as previously described. Breast tissues then underwent estrogen immunocytochemical assay using specific monoclonal antibodies (Abbott Laboratory, Chicago, IL). The cases were evaluated for heterogeneity, intensity of staining, and percentage of positive cells. An attempt was made to study the relation between the pattern of ER expression, nuclear pleomorphism, and type of CIS. The results of ER immunocytochemical assay showed positive nuclear staining for ER in 75% of the CIS, 73% of CIS with invasive cancer, and 100% of atypical hyperplasias. ER expression in CIS agreed with that in the invasive carcinoma in 29 of 30 cases. This study also suggests that comedocarcinoma has a higher incidence of negative ER expression than the other types of CIS, particularly when it is associated with significant nuclear pleomorphism. There was no significant difference in ER tumor heterogeneity between premalignant and malignant lesions. (Key words: Estrogen receptor; Carcinoma in situ; Atypical hyperplasia; Breast cancer) Am J Clin Pathol 1990;94: THE DEVELOPMENT and use of estrogen receptor (ER) assays has led to significant improvements in the therapy ofbreast cancer. Characterizing a carcinoma of the breast by ER status can aid in predicting the aggressiveness of the tumor The presence of ER is associated with favorable cell kinetics and prognosis for the patient.' 01 Those patients with positive tumors, amenable to hormone therapy, may be treated for prolonged periods with endocrine therapy and avoid the undesirable side effects associated with cytotoxic chemotherapy. 19 The profound influence estrogen receptors may have on the progression and outcome ofbreast carcinoma make it a compelling factor to assess in premalignant lesions. Received December 1, 199; received revised manuscript and accepted for publication February 23, This paper was presented at the ASCP/CAP Fall Meeting, Washington, D.C., October 2-November 3, 199, and the 12th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, December -9, 199. Address reprint requests to Dr. Masood: Department of Pathology, University Hospital of Jacksonville, 655 W. th Street, Jacksonville, Florida Department of Pathology, University of Florida Health Science Center, Jacksonville Division, Jacksonville, Florida Extensive studies have provided information regarding ER expression in invasive breast cancers 24 " 6 "; however, relatively few reports have attempted to characterize ER expression in preinvasive breast lesions such as those described by Dupont and Page. 3 Their epidemiologic studies indicate an elevated risk of invasive breast cancer associated with atypical hyperplasia (moderately increased risk: four to five times normal) and carcinoma in situ (high risk: eight to ten times normal). In the recent study, we examined the patterns and degrees of ER positivity in breast carcinoma in situ without an invasive component (CIS), CIS with infiltrating breast cancer (CIS/CA), and atypical hyperplasia (AH) to discern whether there were any distinguishing differences in ER expression between preinvasive lesions (CIS and AH) and CIS/CA. We studied ER expression using monoclonal antibodies, which not only have a high degree of concordance with traditional, cytosolic steroid binding assays 6914 but also offer some unique advantages. The antibody is highly specific and sensitive 5 for nuclear ER and allows ER detection without interference by estrogen, antiestrogens, or other steroid-binding proteins. 15 The use of monoclonal antibodies is ideal on fine-needle aspiration biopsy or when breast lesions are too small for conventional estrogen assays. 1 U2 It provides a further advantage in that the histologic characteristics, as well as the degree of heterogeneity of estrogen receptor positivity, can be simultaneously evaluated. 19 Because no sophisticated equipment is needed and the technique is relatively easy, immunohistochemistry is adaptable to the community hospital." Materials and Methods Paraffin blocks from 62 cases of breast CIS (30 cases with a component of infiltrating carcinoma) and 36 cases of atypical hyperplasia were obtained from the files of the surgical pathology department of University Hospital of Jacksonville, Florida. The reagents used in the immunoperoxidase procedure (including blocking reagents from primary antibody negative control, bridging antibody, peroxidase-antiperoxi- 533
2 534 BARNES AND MASOOD A.J.C.P. November 1990 dase complex [PAP] substrate, and substrate buffer) were obtained from commercially available kits (ICA monoclonal; Abbott Laboratories Chicago, IL). The slides were prepared from paraffin blocks using a method previously described. 2,20 The tissue was cut in 5-fim sections and placed on adhesive slides provided in the ICA kit. They were deparaffinized with toluene and dehydrated through gradient alcohols. Appropriate phosphate-buffered saline (PBS) rinses were performed. All incubations were at room temperature. Protease was applied to each slide and allowed to incubate for 9 minutes. The slides were rinsed, and normal horse serum was used as a blocking agent before primary antibody, bridging antibody, and PAP solutions. The slides were incubated for 10 minutes, and then the primary antibody was applied and incubated overnight. After incubation the bridging antibody was applied and incubated for two hours. The PAP complex was applied and incubated for two hours. The chromogen, diaminobenzidine (DAB), was applied and allowed to react for 10 minutes. Finally, 2% (w/v) osmium tetroxide was used to enhance the DAB reaction, and the slides were counterstained with methyl green. Specimens with a minimum of 20% malignant cells staining positively were considered ER positive. 7 All ERpositive cells exhibited brown nuclear staining. The intensity of staining was evaluated on a scale of The strongest nuclear staining equal to or greater than that of normal breast epithelium was considered 3+, moderate brown staining 2+, and light nuclear staining 1+. Cells without any staining or those showing only minute trace reactions were read as negative. Three hundred cells were characterized in each slide. For semiquantitative analysis, the staining intensity was multiplied by the fraction of positive cells, and this numeric value, the ICA score," was determined for each lesion. The pattern, intensity of ER positivity, and nuclear pleomorphism were evaluated independently by two pathologists (S.M. and R.B.). The pattern was characterized as diffuse if more than 70% cells stained ER positively versus focal if less than 70% cells stained positively, and homogeneous if more than 70% cells stained with optically equal intensity versus heterogeneous if less than 70% cells stained with optically equal intensity. Nuclear pleomorphism was evaluated with hematoxylin and eosin- (H and E) stained slides on the basis of variation in size, chromatin pattern, and hyperchromatism. They were then graded as follows: O no pleomorphism; 1 mild; 2 moderate; and 3 severe nuclear pleomorphism. For semiquantitative analysis, nuclear pleomorphism was graded as 1-3 and multiplied by the fraction of pleomorphic cells to determine the degree of nuclear pleomorphism. Results Positive staining for estrogen receptor proteins was limited to the nucleus of the epithelial cells (normal, hyperplastic, and carcinoma). Seventy-five percent of CIS, 73% of CIS/CA, and 100% of atypical hyperplastic lesions displayed ER positivity. The ICA score was highest in AH, intermediate in CIS, and lowest in CIS/CA and comedocarcinoma in situ (Table 1). A diffuse/heterogeneous pattern was the most frequent finding in all lesions (CIS 34% [Fig. 1], CIS/CA 53%, and atypical hyperplasia 55%). All lesions showed a remarkable degree of ER heterogeneity within each lobule as well as between lobules or portions of tumor. The premalignant lesions displayed a focal pattern of ER (CIS 41%, AH 44%) nearly twice as often as lesions with invasion (CIS/ CA 23%) but with the same degree of heterogeneous staining. The homogeneous pattern was rarely encountered and, when identified, was nearly always the expression of a lesion with low aggressiveness. In most (90%) of the cases with both CIS and invasive CA, the percentage of ER positivity, pattern, and intensity of positive staining were equivalent in the CIS and invasive components (Fig. 2). Nuclear pleomorphism was evaluated as a separate variable and found to correlate inversely with ER positivity in CIS and CIS/CA. A similar inverse relationship has also been described in invasive carcinoma of the breast. 17 Comedocarcinoma in situ was specifically examined as a subset of CIS. ER negativity was found in 46% (6 of 13 cases). A diffuse heterogeneous pattern was most commonly seen (3%) in positive comedocarcinoma. ERpositive comedocarcinoma in situ had a higher degree of nuclear pleomorphism than positive CIS of other types (solid cribriform, etc.) and closely resembled negative cribriform and solid CIS in terms of nuclear pleomorphism. negative comedocarcinoma had the highest degree of nuclear pleomorphism (Table 2). Table 1. Summary of Estrogen Receptor Status and Staining Pattern in Atypical Hyperplasia and Carcinoma In Situ Atypical hyperplasia Carcinoma in situ CIS/CAt Comedo-CIS n %ER * Estrogen receptor immunocytochemical assay. t CIS/CA = carcinoma in situ with invasive cancer. % Diffuse % Focal ICA*
3 Vol. 94 No. 5 ER PATTERN IN BREAST CARCINOMA IN SITU 535 FIG. 1. Most lesions displayed a diffuse and heterogeneous staining pattern for ER. There was wide variation of both interlobular and intralobular staining. ICA, counterstain with methyl green (X200). FIG. 2. Most invasive carcinomas displayed the same ER staining pattern and level of intensity as the adjacent CIS component. ICA counterstain with methyl green (X100). Increasing age in patients with CIS was directly related to ER positivity and inversely related to nuclear pleomorphism (Table 3). This is consistent with studies of breast cancer that have shown nuclear pleomorphism inversely related to ER content and patient age.17 In the current study, the patient population was categorized by age rather than menopausal status, because studies have shown ER expression is a characteristic of the tumor in- dependent of circulating estrogen levels.13 In our study invasive cancer was found more frequently in patients with CIS who were younger than age 55 (14 of 23) than those 55 and older (16 of 39). Atypical hyperplasia exhibited ER positivity in all cases (100%, n = 36). The pattern was most often heterogeneous and diffuse, with wide variations between lobules and within lobules. The patterns in atypical hyperplasia closely
4 536 BARNES AND MASOOD A.J.C.P. November 1990 resembled those of CIS. The nuclei exhibited minimal pleomorphism. There were no significant differences in any of the observed values between younger and older age groups. It is interesting that apocrine metaplasia was consistently ER negative in 21 slides examined. A loss of ER positivity could be traced in areas where ductal epithelium was in the process of undergoing apocrine metaplastic change. Table 3. Summary of Estrogen Receptor (ER) Status and Nuclear Pleomorphism by Age Groups AGE <55 ClSf CIS/CAt >55CIS CIS/CA N %ER* ICA* Nuclear Pleomorphism Discussion The results of this study suggest the dynamics of ER expression previously described in breast carcinoma 17 may apply to breast CIS as well. The ER staining intensity has been shown to be a quantifiable feature that correlates significantly with the ER content by cytosol measurement. The percentages of positive CIS and CIS/CA were equivalent (75% and 73%, respectively). However, the staining intensity reflected by the ICA score was generally greatest in the least aggressive lesions (AH and CIS) and lowest in the more aggressive lesions (CIS/CA). As with breast cancer, 17 the ER expression in our study of breast CIS is generally increased with age and decreased with nuclear pleomorphism. In most cases studied, the estrogen receptor status of invasive carcinoma could be predicted by observing ER status expressed in areas of CIS. In 90% (27 of 30) of our cases of CIS with invasive cancer, the pattern and intensity of the invasive component was similar to that of the CIS component. The three exceptions were one case of ERnegative comedocarcinoma giving rise to an positive ductal carcinoma and two cases of weakly positive CIS developing into a moderately positive carcinoma. Only one case demonstrated discordance in terms of ER positivity and negativity (a 97% concordance rate). Table 2. Summary of Nuclear Pleomorphism Related to Estrogen Receptor (ER) Status in Atypical Hyperplasia (AH) and Carcinoma In Situ (CIS) AH CIS C1S/CA* Comedo-CIS n CIS/CA = carcinoma in situ with invasive cancer. Nuclear Pleomorphism * Estrogen receptor immunocytochemical assay. t Carcinoma in situ. % Carcinoma in situ with invasive cancer. The discrepancies may possibly be explained by regional differences in relative tissue hypoxia or lack of other nutrients. Studies have shown that positive breast tumor cells grown in nutrient-deficient media may lose their ER expression until the deficient nutrient is resupplied. Alternatively, these discrepancies may be associated with tumor heterogeneity. Heterogeneous expression of ER in normal breast epithelium and invasive tumors with the use of monoclonal antibodies has previously been described. 419 Simultaneous investigations of multiple, separate areas of the same tumor mass using biochemical receptor assays have demonstrated discordance rates (ER positive vs. ER negative) ranging from 12.5% to 32%. I9 Intratumor quantitative values in positive cancers show similar discordance. 19 Two previous studies have characterized ER expression in atypical hyperplasia and breast CIS using monoclonal antibodies. Fabris and colleagues 4 studied 150 cases each of benign and malignant breast lesions. CIS and atypical hyperplasia of breast expressed homogeneous ER patterns. Normal breast epithelium and invasive breast cancer stained heterogeneously. The differences in the patterns of ER staining in CIS may be related to the use of different antibodies. Bur and Chowdhary, 1 using a technique similar to that of the current study, reported ER expression predominately diffuse in CIS. ER expression was frequently negative in comedocarcinoma 1/36, especially when associated with nuclear pleomorphism, a finding supported by our study. In the current study ER expression in CIS with and without invasive carcinoma was predominately diffuse and heterogeneous. The degree of nuclear pleomorphism observed is generally inversely related to ER positivity. In comedocarcinoma this relationship is so strong, our study indicates that nuclear pleomorphism may serve as one potential indicator of ER expression. The ER expression of carcinoma could be predicted from the ER expression in the associated CIS lesion with such consistency that a discordant ER expression between a biopsy of CIS
5 Vol. 94. No. 5 and subsequent invasive carcinoma necessitates additional study to evaluate the heterogeneity of ER expression within the tumor and to establish true ER status. References ER PATTERN IN BREAST CARCINOMA IN SITU Bur M, Chowdhary S. Estrogen and progesterone receptor immunohistochemistry in carcinoma in situ of the breast with paraffin embedded sections. Abstract presented at the International Academy of Pathology Annual Meeting, San Francisco, March Cheny L, Binder S, Fu Y, Lewin K. Demonstration of estrogen receptors by monoclonal antibody in formalin fixed breast tumor. Lab Invest 19.5: Dupont WD, Page OL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 195;312: Fabris G, Marchetti E, Morgola A, Bogni A, Quezoli P, Nenci I. Pathophysiology of estrogen receptor in mammary tissue by monoclonal antibodies. J Steroid Biochem 197;27: Ghosh L, Ghosh BC, Dasgupta TK. Immunocytological localization of estrogen in human mammary carcinoma cells by horseradishanti-horseradish peroxidase complex. J Surg Oncol 197; 10: Greene GL, Jensen EB. Monoclonal antibodies as probes for estrogen receptor detection and characterization. J Steroid Biochem 192;16: Hayward JL, Rubens RD, Carbone PP, Heuson J-C, Kumaoka S, SegalaffA. Assessment of response to therapy in advanced breast cancer. A project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Br J Cancer 1977;35: Jakesy R, Smith CA, Aitken S, et al. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF- 7 breast cancer cells. Cancer Res 194;44: King WJ, DeSombre ER, Jensen EV. et al. Comparison of immunocytochemical and steroid binding assays for estrogen receptors in human breast tumor. Cancer Res 195;45: Kute TE, Muss HB, Anderson D, Crumb K. et al. Relationship of steroid receptor, cell kinetics and clinical status in patients with breast cancer. Cancer Res 191;41: Masood S. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimens from patients with breast cancer. Arch Pathol Lab Med 199:113: Masood S, Johnson H. The value of imprint cytology in cytochemical detection of steroid hormone receptors in breast cancer. Am J Clin Pathol 197;7: Mass H, Engel B, Trems G. Steroid hormone receptors in human breast cancer and the clinical significance. J Steroid Biochem 1975;6: McCarthy KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analysis. correlation of biochemical and immunohistochemical methods using monoclonal anti-receptor antibodies. Arch Pathol Lab Med 195;109: Meredith JT, McBride RC, Cerejo L. Estrogen receptors in breast cancer. J Fla Med Assoc 19;75: Meyer JS, Baier WC, Rao BR. Subpopulation of breast carcinoma defined by S-phase fraction, morphology and estrogen receptor content. Lab Invest 197;39: Meyer JS, Lee JY. Relationships of S-phase fraction of breast carcinomas in relapse to duration of remission estrogen receptor content, therapeutic responsiveness and duration of survival. Cancer Res 190;40: Meyer JS, Rao BR, Stevens SC, White WL. Low incidence of estrogen receptors in breast carcinomas with rapid rates of cellular replication. Cancer 197:40: Osborne CK. Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Semin Oncol 195:12: Shintaku IP, Said JW. Detection of estrogen receptors with monoclonal antibodies and routinely processed formalin fixed paraffin sections of breast carcinoma. Am J Clin Pathol 196;7:
Immunohistochemical studies (ER & Ki-67) in Proliferative breast lesions adjacent to malignancy
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 13, Issue 3 Ver. IV. (Mar. 2014), PP 84-89 Immunohistochemical studies (ER & Ki-67) in Proliferative
More informationInterpretation of Breast Pathology in the Era of Minimally Invasive Procedures
Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Medical Director, UF Health Breast Center Chief of Pathology
More informationHer-2/neu expression and its correlation with ER status and various clinicopathological parameters
Original Research Article DOI: 10.5958/2394-6792.2016.00106.X Her-2/neu expression and its correlation with ER status and various clinicopathological parameters Kriti Chauhan 1,*, Monika Garg 2, Abhimanyu
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationProliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease
Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and
More informationImmunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers
Breast Cancer Vol. 14 No. 1 January 2007 Original Article Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers
More informationTreatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea
Treatment options for the precancerous Atypical Breast lesions Prof. YOUNG-JIN SUH The Catholic University of Korea Not so benign lesions? Imaging abnormalities(10% recall) lead to diagnostic evaluation,
More informationPatterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma
Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma Hadia. Mohammed. Abdalla. Abdalrhman *, Elsadig.A.Adam, Ayda.D.A.Allatif 3,'Namareg.E.Afadul
More information# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer
#1034 - Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer Richard W. Cartun, MS, PhD Andrew Ricci, Jr, MD Department of Pathology Hartford
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationBrief Formalin Fixation and Rapid Tissue Processing Do Not Affect the Sensitivity of ER Immunohistochemistry of Breast Core Biopsies
Brief Formalin Fixation and Rapid Tissue Processing Do Not Affect the Sensitivity of ER Immunohistochemistry of Breast Core Biopsies Victoria Sujoy, MD, Mehrdad Nadji, MD, and Azorides R. Morales, MD From
More informationCorrelation Between GATA-3, Ki67 and p53 Expressions to Histopathology Grading of Breast Cancer in Makassar, Indonesia
Cancer Research Journal 2016; 4(3): 43-47 http://www.sciencepublishinggroup.com/j/crj doi: 10.11648/j.crj.20160403.11 ISSN: 2330-8192 (Print); ISSN: 2330-8214 (Online) Correlation Between GATA-3, Ki67
More informationBreast pathology. 2nd Department of Pathology Semmelweis University
Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/
More informationQuality Assurance and Quality Control in the Pathology Dept.
Quality Assurance and Quality Control in the Pathology Dept. Judith Sandbank M.D. Pathology Assaf-Harofeh Medical Center ISRAEL jsandbank@asaf.health.gov.il 2 nd IBDC, 9 th February, 2012 Pathology as
More informationBREAST PATHOLOGY. Fibrocystic Changes
BREAST PATHOLOGY Lesions of the breast are very common, and they present as palpable, sometimes painful, nodules or masses. Most of these lesions are benign. Breast cancer is the 2 nd most common cause
More informationCellular Dyscohesion in Fine-Needle Aspiration of Breast Carcinoma Prognostic Indicator for Axillary Lymph Node Metastases?
natomic Pathology / PROGNOSTIC INDICTOR FOR XILLRY LYMPH NODE METSTSES Cellular Dyscohesion in Fine-Needle spiration of reast Carcinoma Prognostic Indicator for xillary Lymph Node Metastases? nne. Schiller,
More information3/27/2017. Disclosure of Relevant Financial Relationships. Papilloma???
Management of Papillary Lesions Diagnosed at Rad Path Concordant Core Biopsy (CNB) Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationImmunohistochemistry of Estrogen and Progesterone Receptors Reconsidered Experience With 5,993 Breast Cancers
natomic Pathology / ESTROGEN ND PROGESTERONE RECEPTORS IN REST CNCER Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered Experience With 5,993 reast Cancers Mehrdad Nadji, MD, Carmen
More information1 NORMAL HISTOLOGY AND METAPLASIAS
1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous
More informationBreast Pathology. Breast Development
Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th
More informationCLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES
Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated
More informationLYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR
BREAST LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR HISTOLOGY LOBE: (10 in whole breast) LOBULE: (many per lobe) ACINUS/I, aka ALVEOLUS/I: (many per lobule) DUCT(S): INTRA- or
More informationImmunohistochemical classification of breast tumours
Immunohistochemical classification of breast tumours Workshop in Diagnostic Immunohistochemistry September 19 th - 21 th 2018 Anne-Vibeke Lænkholm Department of Surgical Pathology, Zealand University Hospital,
More informationACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016
Diagnosing Mesothelioma in Limited Tissue Samples Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Sanja Dacic, MD, PhD University of Pittsburgh ACCME/Disclosures GENERAL RULES
More informationACCME/Disclosures. Cribriform Lesions of the Prostate. Case
Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires
More informationCytyc Corporation - Case Presentation Archive - March 2002
FirstCyte Ductal Lavage History: 68 Year Old Female Gail Index: Unknown Clinical History: Negative Mammogram in 1995 6 yrs. later presents with bloody nipple discharge Subsequent suspicious mammogram Suspicious
More informationEstrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women
Journal of Bangladesh College of Physicians and Surgeons Vol. 28, No. 3, September 2010 Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women
More informationDifferentiation of Tumors with Specific Red Cell Adherence (SRCA) test
753 Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test Dr. Abhishek A Mangaonkar *, Dr. A G Valand 1 Intern, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India 2 Professor,
More informationSurgical Pathology Issues of Practical Importance
Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast
More information04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES
Pathology Perspectives of High Risk Breast Lesions Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head Director of Clinical Trials, Research and Development The University of Texas MD
More informationDiagnostic Value of Imprint Cytology During Image-Guided Core Biopsy in Improving Breast Health Care
Available online at www.annclinlabsci.org 8 Annals of Clinical & Laboratory Science, vol. 41, no. 1, 2011 Diagnostic Value of Imprint Cytology During Image-Guided Core Biopsy in Improving Breast Health
More informationA712(19)- Test slide, Breast cancer tissues with corresponding normal tissues
A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding
More informationComparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma
J Clin Pathol 1;54:951 955 951 Department of Pathology, University of Wales College of Medicine, Heath Park, CardiV, South Glamorgan, CF14 4XN, UK A G Douglas-Jones N Collett J M Morgan B Jasani Correspondence
More informationLOBULAR CARCINOMA IN SITU: WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE
: WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University of Washington Joint Member, Fred Hutchinson Cancer
More informationBenign Breast Disease and Breast Cancer Risk
Benign Breast Disease and Breast Cancer Risk Jean F. Simpson, M.D. Vanderbilt University Nashville, Tennessee December 1, 2011 Nashville Nashville Lebanon 1 Cedars of Lebanon State Park The American University
More informationMammary Nodular Hyperplasia in Intact R hesus Monkeys
Vet. Path. 10: 130-134 (1973) Mammary Nodular Hyperplasia in Intact R hesus Monkeys L. W NELSON and L. D. SHOTT Department of Pathology and Toxicology, Mead Johnson Research Center, Evansville, Ind., and
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationGood afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting
PATHOLOGY IN-SITU CARCINOMA, ROHIT BHARGAVA, MD 1 Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting me here, it s great to be here and I m going to talk about
More informationEpithelial Columnar Breast Lesions: Histopathology and Molecular Markers
29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar
More informationImmunohistochernical Estrogen Receptor Determination in Human Breast Carcinoma: Correlation with Histologic Differentiation and Age of the Patients
Immunohistochernical Estrogen Receptor Determination in Human Breast Carcinoma: Correlation with Histologic Differentiation and Age of the Patients Pages with reference to book, From 133 To 136 S. Pervez,
More informationA712(18)- Test slide, Breast cancer tissues with corresponding normal tissues
A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding
More informationCarcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS
Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific
More informationER- 36, a Novel Variant of ER-, is Expressed in ER-positive and -negative Human Breast Carcinomas
ER- 36, a Novel Variant of ER-, is Expressed in ER-positive and -negative Human Breast Carcinomas LISA M.J. LEE 1, JIANG CAO 3, HAO DENG 4, PING CHEN 3, ZORAN GATALICA 1 and ZHAO-YI WANG 1,2 1 Department
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationDivision of Oncology/Hematology, Department of Medicine, Winthrop-University Hospital, 200 Old Country Road, Suite 450, Mineola, NY 11501, USA 2
International Scholarly Research Network ISRN Oncology Volume 2011, Article ID 673790, 5 pages doi:10.5402/2011/673790 Clinical Study Study of Estrogen Receptor and Progesterone Receptor Expression in
More information6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies
Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS
More informationFAQs for UK Pathology Departments
FAQs for UK Pathology Departments This is an educational piece written for Healthcare Professionals FAQs for UK Pathology Departments If you would like to discuss any of the listed FAQs further, or have
More informationDisclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012
Disclosures Parathyroid Pathology I have nothing to disclose Annemieke van Zante MD/PhD Assistant Professor of Clinical Pathology Associate Chief of Cytopathology Objectives 1. Review the pathologic features
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Texas Society of Pathologists 2013 Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical
More informationPathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY
Pathology of Lobular & Ductal Preneoplasia Syed A Hoda, MD Weill-Cornell, New York, NY Proliferative Epithelial Changes in Breast A wide range of proliferative epithelial changes occur in the breast There
More informationPalpable Breast Lesions Cytomorphological Analysis and Scoring System with Histopatholgical Correlation
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 10 Ver. III (October. 2016), PP 25-29 www.iosrjournals.org Palpable Breast Lesions Cytomorphological
More informationPh.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE Ph.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY SCIENTIFIC COORDINATOR: PROF. DR. MIHAI B. BRĂILA, Ph.D. Ph.D. Graduand:
More informationINTRA-OPERATIVE CYTOLOGY AND FROZEN SECTIONS OF BREAST LESIONS: A COMPARISON FROM A SAUDI TEACHING HOSPITAL
Bahrain Medical Bulletin, Volume 18, Number 1, March 1996 INTRA-OPERATIVE CYTOLOGY AND FROZEN SECTIONS OF BREAST LESIONS: A COMPARISON FROM A SAUDI TEACHING HOSPITAL Ammar C.Al-Rikabi, MD,MRCPath,FIAC*
More informationDIAGNOSTIC DILEMMA. Case Reports Clinical history. Materials and Methods
DIAGNOSTIC DILEMMA A Metastatic Renal Carcinoid Tumor Presenting as Breast Mass: A Diagnostic Dilemma Farnaz Hasteh, M.D., 1 Robert Pu, M.D., Ph.D., 2 and Claire W. Michael, M.D. 2 * We present clinicopathological
More informationContents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ
Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5
More informationMinimizing Errors in Diagnostic Pathology
Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine-Jacksonville Medical Director, Shands Jacksonville Breast Health Center
More informationSenior of Histopathology Department at Khartoum, Radiation and Isotopes Center
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 2/ May 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Immune Histochemical Evaluation of AMACR (P504S) in Prostatic Adenocarcinoma
More informationTriple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
More informationCase Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.
Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to
More informationDr. dr. Primariadewi R, SpPA(K)
Curriculum Vitae Dr. dr. Primariadewi R, SpPA(K) Education : Medical Doctor from UKRIDA Doctoral Degree from Faculty of Medicine University of Indonesia Pathologist Specialist and Consultant from Faculty
More informationDuctal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA
Ductal Carcinoma in Situ Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Definition of DCIS WHO 2012 A neoplastic proliferation
More informationDisclosures. Premalignant Lesions of the Breast: What Clinicians Want and Why. NY Times: Prone to Error: Earliest Steps to Find Cancer.
Disclosures Premalignant Lesions of the Breast: What Clinicians Want and Why I have nothing to disclose Rick Baehner, MD Assistant Professor, UCSF Pathology NY Times: Prone to Error: Earliest Steps to
More informationRSNA, /radiol Appendix E1. Methods
RSNA, 2016 10.1148/radiol.2016151097 Appendix E1 Methods US and Near-infrared Data Acquisition Four optical wavelengths (740 nm, 780 nm, 808 nm, and 830 nm) were used to sequentially deliver the light
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationAtypical Hyperplasia/EIN
EIN Atypical Hyperplasia/EIN Based on scientific and diagnostic advances, in 2014 the WHO moved that the precursor lesion for endometrioid carcinoma be atypical hyperplasia/ein, rather than what was previously
More informationEnterprise Interest None
Enterprise Interest None B3 lesions of the breast What are they at surgery? Case 4 Edi Brogi MD PhD Attending Pathologist - Director of Breast Pathology Memorial Sloan Kettering Cancer Center New York
More informationPathologic Features of Breast Cancers in Women With Previous Benign Breast Disease
Anatomic Pathology / BREAST CANCERS AFTER BENIGN BIOPSY DIAGNOSES Pathologic Features of Breast Cancers in Women With Previous Benign Breast Disease Timothy W. Jacobs, MD, 1 Celia Byrne, PhD, 2 Graham
More informationDr. Issraa Ali Hussein
CLINICAL 09888888;rCYTOLOGY Dr. Issraa Ali Hussein objectives Define diagnostic cytology (clinical cytology). Explain the differences between histopathology and cytopathology. Recognize the methods for
More informationCell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-
Supplemental material and methods Reagents. Hydralazine was purchased from Sigma-Aldrich. Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC- 133, human thyroid medullary
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationISPUB.COM. C Choccalingam, L Rao INTRODUCTION ESTROGEN AND PROGESTERONE RECEPTORS
ISPUB.COM The Internet Journal of Pathology Volume 13 Number 1 Learning Experience In Immunohistochemical Reporting Of Breast Cancer At A Rural Tertiary Hospital In India: A Comparison In Initial And Reviewed
More informationOriginal Article. Spontaneous Healing of Breast Cancer
Breast Cancer Vol. 12 No. 2 April 2005 Original Article Rie Horii 1, 3, Futoshi Akiyama 1, Fujio Kasumi 2, Morio Koike 3, and Goi Sakamoto 1 1 Department of Breast Pathology, the Cancer Institute of the
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationDisclosure of Relevant Financial Relationships. Breast Pathology Evening Specialty Conference Case #4. Clinical Case: Pathologic Features
Breast Pathology Evening Specialty Conference Case #4 K.P. Siziopikou, MD, PhD Professor of Pathology Director of Breast Pathology and Breast Pathology Fellowship Program Northwestern University Feinberg
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationCPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.
CPC 4 Breast Cancer Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. 1. What are the most likely diagnoses of this lump? Fibroadenoma
More informationThe Incidence of Breast Cancer in Examined Biopsies of Breast Masses in Al-Hussain Teaching Hospital in Kerbala
Iraqi JMS Published by Al-Nahrain College of Medicine ISSN 1681-6579 Email: iraqijms@colmed-alnahrain.edu.iq http://www.colmed-alnahrain.edu.iq The Incidence of Breast Cancer in Examined Biopsies of Breast
More informationXXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology
XXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology NUEVOS FENOTIPOS DEL CÁNCER DE MAMA: NUEVOS PROBLEMAS PARA EL PATÓLOGO? Tienen actualmente
More informationTable of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS
Staining Atlas Table of Contents 1. Overview 1.1 Introduction 1.2 Role of p16 INK4a 1.3 Role of Ki-67 1.4 Molecular Pathogenesis 1.5 p16 INK4a Expression in Cervical Dysplasia 1.6 The Concept of CINtec
More informationRadiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging
Radiation and DCIS The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation Oncology
More informationCOMPANION MEETING BREAST. Auditorium 11:15 1:00 am. Convenor: A/Professor Gelareh Farshid, SA Pathology, SA
Australasian Division of the International Academy of Pathology Limited ABN 73 008 593 815 36 TH Annual Scientific Meeting Darling Harbour Convention Centre, Sydney, Australia June 3-5, 2011 COMPANION
More informationQuestion 1 A. ER-, PR-, HER+ B. ER+, PR+, HER2- C. ER-, PR+, HER2- D. ER-, PR-, HER2- E. ER-, PR+, HER2+
Triple Negative Breast Cancer Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA Question 1 The tumor depicted on the next slide
More informationValue of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions
Romanian Journal of Morphology and Embryology 2006, 47(4):351 355 ORIGINAL PAPER Value of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions LILIANA MOCANU 1), ANCA
More informationAssessment of Her-2/neu Overexpression in Primary Breast Cancers and Their Metastatic Lesions: An Immunohistochemical Study
Annals o f Clinical & Laboratory Science, vol. 30, no. 3, 2000 259 Assessment of Her-2/neu Overexpression in Primary Breast Cancers and Their Metastatic Lesions: An Immunohistochemical Study Shahla Masood
More informationTitle: Spontaneous Feline Mammary Intraepithelial Lesions as a Model for Human Estrogen Receptor- and Progesterone Receptor-Negative Breast Lesions
Author's response to reviews Title: Spontaneous Feline Mammary Intraepithelial Lesions as a Model for Human Estrogen Receptor- and Progesterone Receptor-Negative Breast Lesions Authors: Giovanni P Burrai
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationSalivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
More informationUpdate in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016
Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish
More informationPSA. HMCK, p63, Racemase. HMCK, p63, Racemase
Case 1 67 year old male presented with gross hematuria H/o acute prostatitis & BPH Urethroscopy: small, polypoid growth with a broad base emanating from the left side of the verumontanum Serum PSA :7 ng/ml
More informationINTRODUCTION TO PATHOLOGICAL TECHNIQUES. 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH)
INTRODUCTION TO PATHOLOGICAL TECHNIQUES 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH) Biopsy-Indications Diffuse/multifocal lesions (neoplastic, inflammatory, etc) Etiology of the
More informationThey Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples
They Do Look Alike : in Biopsy Samples Gladell P. Paner, MD Departments of Pathology and Surgery (Urology) University of Chicago, IL USA Gladell.paner@uchospitals.edu Benign in Needle Biopsy 1. Benign
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationClaudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression
Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Mona A. Abd-Elazeem, Marwa A. Abd- Elazeem Pathology department, Faculty of Medicine, Tanta
More informationRare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence
Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival
More informationACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION
POL J PATHOL 2011; 2: 95-100 ACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION OF MALIGNANT PLEURAL AND PERITONEAL EFFUSIONS FERESHTEH ENSANI, FARNAZ NEMATIZADEH, GITI IRVANLOU Department of Cytology, Cancer
More informationMolecular Characterization of Breast Cancer: The Clinical Significance
Molecular Characterization of : The Clinical Significance Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine-Jacksonville
More informationEndometrial Metaplasia, Hyperplasia & Other Cancer Mimics: a Consultant s Experience
Endometrial Metaplasia, Hyperplasia & Other Cancer Mimics: a Consultant s Experience Pacific Northwest Society of Pathologists Vancouver, B.C. September 26, 2015 Teri A. Longacre, M.D. longacre@stanford.edu
More information